Januvia (sitagliptin)
JANUVIA (sitagliptin) – a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. DPP-4 inhibitors, are believed to exert their actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. By increasing and prolonging active incretin levels, […]